ABILITY PHARMA
Live / Applied — Ex parte appeal pending (as of 20 Jul 2026)
What this means for you
Not registered yet, but its 30 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79416504
- Mark type
- Word mark
- Filed
- 30 Sept 2024
- Attorney of record
- MELISSA DANGOND
Goods and services
- Class 042 — Scientific and technological services: Scientific and technological research activities for development of new drugs and medicines; Technical consultancy in the field of pharmaceutical studies, in particular relating to evaluations, estimates, and reports prepared in the course of scientific and technological research in the field of pharmaceutical medicines; Industrial analysis, namely, analysis of pharmacokinetics, pharmacodynamics and biomarkers related to drugs and medicines or pathologies to assure compliance with industry standards; Industrial research in the field of medicine
Owner
Board proceedings on this mark
- Ex Parte Appeal No. 79416504 — Ability Pharmaceuticals, S.A., filed 18 May 2026 (Awaiting Expiration of Appeal Period)
Prosecution history
- 12 May 2026 — DIVISIONAL REQUEST RECEIVED
- 22 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 May 2026 — ASSIGNED TO LIE
- 18 May 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 18 May 2026 — EX PARTE APPEAL-INSTITUTED
- 18 May 2026 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 18 May 2026 — EXPARTE APPEAL RECEIVED AT TTAB
- 12 May 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 12 Feb 2026 — LIMITATION OF GOODS RECEIVED FROM IB
- 01 Jan 2026 — LIMITATION OF GOODS RECEIVED FROM IB
- 19 Nov 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 19 Nov 2025 — FINAL REFUSAL E-MAILED
- 19 Nov 2025 — FINAL REFUSAL WRITTEN
- 22 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE